Precision Optics Corporation, Inc. (POCI)
NASDAQ: POCI · Real-Time Price · USD
4.600
+0.290 (6.73%)
Nov 6, 2024, 4:00 PM EST - Market closed
Company Description
Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States.
The company offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians.
It also provides components and assemblies for industrial and military use. It markets its products to medical device companies.
Precision Optics Corporation, Inc. was incorporated in 1982 and is based in Gardner, Massachusetts.
Precision Optics Corporation, Inc.
Country | United States |
Founded | 1982 |
Industry | Medical Instruments & Supplies |
Sector | Healthcare |
Employees | 84 |
CEO | Joseph Forkey |
Contact Details
Address: 22 East Broadway Gardner, Massachusetts 01440 United States | |
Phone | 978 630 1800 |
Website | poci.com |
Stock Details
Ticker Symbol | POCI |
Exchange | NASDAQ |
Fiscal Year | July - June |
Reporting Currency | USD |
CIK Code | 0000867840 |
CUSIP Number | 740294400 |
ISIN Number | US7402944000 |
Employer ID | 04-2795294 |
SIC Code | 3845 |
Key Executives
Name | Position |
---|---|
Richard E. Forkey | Founder, Advisor to the Chief Executive Officer and Director Emeritus |
Dr. Joseph N. Forkey | Chief Executive Officer, President, Treasurer and Director |
Wayne M. Coll | Chief Financial Officer and Secretary |
Mahesh Lawande | Chief Operating Officer |
Clay Schwabe | Vice President of Sales and Marketing |
Stephanie R. Hansen | Director of Human Resources |
Divaker Mangadu | President of Ross Optical Division |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Oct 28, 2024 | 10-K/A | [Amend] Annual report |
Oct 1, 2024 | 8-K | Current Report |
Sep 30, 2024 | 10-K | Annual Report |
Aug 15, 2024 | 424B5 | Filing |
Aug 14, 2024 | 8-K | Current Report |
Jul 3, 2024 | 8-K | Current Report |
Jun 14, 2024 | EFFECT | Notice of Effectiveness |
Jun 11, 2024 | S-3/A | [Amend] Registration statement under Securities Act of 1933 |
Jun 11, 2024 | UPLOAD | Filing |
Jun 7, 2024 | S-3 | Registration statement under Securities Act of 1933 |